SoCal's Vical Terminates 54% of Workforce to Focus Resources on Two Clinical Programs Post author:Sam Post published:January 30, 2018 Post category:BioPharma Vical announced its restructuring late Tuesday. Source: BioSpace You Might Also Like EyeGate Implodes as Eye Drug Flunks Phase II Test February 4, 2018 Adaptimmune Sees Positive Early Results in Cancer Treatment March 15, 2018 Bay Area's Adamas Pharma Pays Big Bucks to Double HQ January 21, 2018
